Research and Clinical Trials

Researchers find that a gene may play a role in causing people with telomere biology disorders to have a high risk of developing blood cancer.

Mayo Clinic research has filled critical gaps in the understanding of how breast cancer genes predispose women to the disease.

Researchers built a highly accurate artificial intelligence model for fully automated cancer detection, including small and otherwise difficult-to-detect tumors.

Dr. Lida Mina says treatment for metastatic breast cancer has advanced, allowing people to live longer with a better quality of life.

Researchers have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy.

Researchers at Mayo Clinic are studying a vaccine-immunotherapy combination to stop ovarian cancer from progressing.

Dr. Judy Boughey explains why some people with multiple tumors may be able to receive a lumpectomy followed by whole-breast radiation therapy.

A condensed hypofractionated schedule of proton therapy resulted in excellent control of cancer while sparing surrounding tissue.

Yan Asmann, Ph.D., and Aaron Mansfield, M.D., are leading an effort to reduce racial disparities in genomic data to improve the diagnosis and treatment of cancer.

Findings can assist care teams in predicting if someone with advanced colorectal cancer will benefit from immunotherapy.